Welcome to the future of oncohematology and immunology clinical research with BD Biosciences, offering an extensive range of cutting-edge reagents designed to elevate your research. BD Cytognos™ brings a commercialized approach to standardization of multicolor flow cytometry. BD Cytognos™ collaborates actively with the EuroFlow™ consortium implementing and bringing the Next Generation Flow™ approach onto the market, which provides highly sensitive RUO flow cytometry hematological malignancy, minimal residual disease and primary immunodeficiencies assays for clinical research. From this portfolio we have leveraged ASR and RUO offerings of both single-color reagents and pre-defined kit solutions (RUO) in the U.S.
Explore our integrated BD Cytognos™ Reagent portfolio to enhance your clinical research capabilities.